ArticleOncotarget2018

Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graft-versus-host disease: a multicenter prospective study.

Sophie Servais et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.